ATARA BIOTHERAPEUTICS, INC. Repayment of Notes Receivable from Related Parties
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Repayment of Notes Receivable from Related Parties of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RepaymentOfNotesReceivableFromRelatedParties · last filed 2017-03-09
- ATARA BIOTHERAPEUTICS, INC. repayment of notes receivable from related parties for the quarter ending 2014-12-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. repayment of notes receivable from related parties for the quarter ending 2014-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. repayment of notes receivable from related parties for fiscal 2016 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. repayment of notes receivable from related parties for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- ATARA BIOTHERAPEUTICS, INC. repayment of notes receivable from related parties for fiscal 2014 was $337.00K.
| Period end | Repayment of Notes Receivable from Related Parties 3 month | Repayment of Notes Receivable from Related Parties 6 month | Repayment of Notes Receivable from Related Parties 9 month | Repayment of Notes Receivable from Related Parties 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-09 | $337.00K 10-K · filed 2017-03-09 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $337.00K 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $337.00K 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |